Serial serum procalcitonin changes in the prognosis of acute stroke

Authors

Spyridon Miyakis, University of AthensFollow
Petros Georgakopoulos, University of Athens
Maria Kiagia, University of Athens
Angelos Pefanis, ''Sotiria'' Chest Diseases And General Hospital
Theodoros D. Mountokalakis, University of Athens
Olga Papadopoulou, University of Athens
Aristomenis Gonis, ''Sotiria'' Chest Diseases And General Hospital

RIS ID

74479

Publication Details

Miyakis, S., Georgakopoulos, P., Kiagia, M., Pefanis, A., Mountokalakis, T. D., Papadopoulou, O. & Gonis, A. (2004). Serial serum procalcitonin changes in the prognosis of acute stroke. Clinica Chimica Acta, 350 (1/2), 237-239.

Abstract

Inflammatory response is a principal early component in the pathophysiology of stroke [1]. Serum procalcitonin (PCT)-a marker of septicemia and infection severity [2]-has also been proposed as an indicator of systemic inflammatory response in noninfectious situations [3,4]. As no data exist thus far on PCT in stroke, this study aimed to evaluate serum PCT changes in the acute stroke setting, and to correlate them with clinical and laboratory parameters and patient's outcome.